Common variations in four genes related to brain inflammation or cells' response to damage from oxidation may contribute to the problems with memory, learning and other cognitive functions seen in children treated for acute lymphoblastic leukemia, according to a research. The findings suggest the possibility of screening ALL patients for their risk of long-term treatment-related effects on memory, attention and learning and studying potential interventions.